Introduced January 21, 2026 by Diana DeGette · Last progress January 21, 2026
This bill strengthens protections for merit‑based research funding and grant continuity by defining 'political employee' and restricting political appointee participation, while trading off increased administrative burdens, potential reclassification of staff (with attendant job‑security impacts), reduced executive flexibility, and risks of slowed responses or legal disputes over the new rules.
Researchers, institutions, and grant applicants are more likely to have NIH/ARPA‑H funding decisions made on merit rather than political influence because political appointees are restricted from participating in program management and grant decisions.
Researchers and award recipients keep NIH grants, contracts, and cooperative agreements active for their full agreed period unless formal written findings of fraud, mismanagement, debarment, or malfeasance are produced, reducing abrupt funding interruptions.
Federal agencies (HHS/NIH) get a clearer, more uniform definition of 'political employee,' improving consistency in applying PHSA rules to appointees and reducing disputes over who is covered.
Many federal staff (SES noncareer, Schedule C/G, designees) could be newly classified as political employees and thus face reduced civil‑service protections and greater job insecurity.
Implementing, tracking, and enforcing the new definitions and prohibitions will create additional administrative burden and compliance costs for HHS/NIH/ARPA‑H, diverting staff time and resources and potentially delaying grant processes.
An unclear or contested definition of 'political employee' could generate confusion, litigation, and hiring delays as agencies and courts sort out who is barred from participation.
Based on analysis of 5 sections of legislative text.
Bars most political appointees from NIH/ARPA‑H management and funding decisions, requires a report on recent political participation, and limits cancelling or suspending awards absent documented wrongdoing.
Prohibits most political appointees from working in or making policy at the National Institutes of Health (NIH) and from taking part in NIH or ARPA‑H grant and contract decisions. Requires the NIH Director to report past political‑employee participation in funding decisions and limits when the Secretary can cancel, delay, or suspend research awards, including a requirement to notify relevant congressional committees and provide written findings for such actions.